1,112
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessing the Effectiveness of the COPD Assessment Test (CAT) to Evaluate COPD Severity and Exacerbation Rates

, , , &

References

  • Jones PW, Harding G, Berry P, Development and first validation of the COPD assessment test. Eur Respir J 2009 Sep; 34(3):648–654.
  • Wedzicha JA, Seemungal TA. COPD exacerbations: Defining their cause and prevention. Lancet 2007 Sep; 370(9589):786–796.
  • Yorgancıoğlu A, Polatlı M, Aydemir O. Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks 2012 Dec; 60(4):314–320.
  • Quanjer PH, Tammeling GJ, Cotes JE, Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of European Respiratory Society. Eur Respir J Supp 1993 Mar; 16:5–40.
  • GOLD executive committee. Global strategy for diagnosis, management and prevention of COPD, (updated 2009; accessed 2010 July 1). Avaliable from: http://www.golcopd.com.
  • Celli BR, MacNee W. ATS/ERS Task Force. Standarts for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6):932–946.
  • Anthonisen NR, Manfreda J, Warren CP, Antibiotic therapy in exacerbations of cronic obstructive pulmonary disease. Ann Intern Med 1987 Feb; 106(2):196–204.
  • Jones PW, Brusselle G, Dal Negro RW, Properties of the COPD assesment test in a cross sectional European study. Eur Respir J 2011 Jul; 47(1):1019–1024.
  • Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012 Feb; 9(1):12-5.
  • Al-Moamary MS, Al-Hajjaj MS, Tamim HM, The reliability of an Arabic translation of the chronic obstructive pulmonary disease assessment test. Saudi Med J 2011 Oct; 32(10):1028–1033.
  • Chai JJ, Liu T, Cai BQ. Evaluation of clinical significance of chronic obstructive pulmonary disease assessment test. Zhonghua Jie He He Hu Xi Za Zhi 2011 Apr; 34(4):256–258.
  • Dodd JW, Hogg L, Nolan J, The COPD assessment test (CAT) response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011 May; 66(5):425–429.
  • Jones PW, Harding G, Wiklund I, Tests of the responsiveness of the chronic obstructive pulmonary disease (COPD) assessment test TM (CAT) following acute exacerbation and pulmonary rehabilitation. Chest 2012 Jul; 142(1):134–140.
  • Garcia-Aymerich J, Farrero E, Felez MA, Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003 Feb; 58(2):100–105.
  • Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005 Nov; 60(11):925–931.
  • Donaldson GC, Seemungal TA, Bhowmik A, Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2008 Oct; 57(10):847–852.
  • Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax 2006 Feb; 61(2):164–168.
  • Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012 Jun 1; 185(11):1218–1224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.